Capsular glycan recognition provides antibody-mediated immunity against tuberculosis

Antibody-based vaccine strategies against intracellular pathogens

(2018) Arturo Casadevall   CURRENT OPINION IN IMMUNOLOGY

Updates on antibody functions in Mycobacterium tuberculosis infection and their relevance for developing a vaccine against tuberculosis

(2018) Jacqueline M Achkar et al.   CURRENT OPINION IN IMMUNOLOGY

Characterization of the Antigenic Heterogeneity of Lipoarabinomannan, the Major Surface Glycolipid ofMycobacterium tuberculosis, and Complexity of Antibody Specificities toward This Antigen

(2018) Alok Choudhary et al.   JOURNAL OF IMMUNOLOGY

Recent Advances in the Synthesis of Glycoconjugates for Vaccine Development

(2018) Cinzia Colombo et al.   MOLECULES

Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination

(2018) Elisa Nemes et al.   NEW ENGLAND JOURNAL OF MEDICINE

Elevated IgG Responses in Infants Are Associated With Reduced Prevalence of Mycobacterium tuberculosis Infection

(2018) Erin Logan et al.   Frontiers in Immunology

Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis

(2018) Olivier Van Der Meeren et al.   NEW ENGLAND JOURNAL OF MEDICINE

Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection

(2018) Matthew K. O’Shea et al.   Scientific Reports

Latently and uninfected healthcare workers exposed to TB make protective antibodies againstMycobacterium tuberculosis

(2017) Hao Li et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Enhanced control of Mycobacterium tuberculosis extrapulmonary dissemination in mice by an arabinomannan-protein conjugate vaccine

(2017) Rafael Prados-Rosales et al.   PLoS Pathogens

A Functional Role for Antibodies in Tuberculosis

(2016) Lenette L. Lu et al.   CELL

Human isotype‐dependent inhibitory antibody responses against Mycobacterium tuberculosis

(2016) Natalie Zimmermann et al.   EMBO Molecular Medicine

Association of Human Antibodies to Arabinomannan With Enhanced Mycobacterial Opsonophagocytosis and Intracellular Growth Reduction

(2016) Tingting Chen et al.   JOURNAL OF INFECTIOUS DISEASES

The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling

(2016) Rein M. G. J. Houben et al.   PLOS MEDICINE

Patients with Tuberculosis Have a Dysfunctional Circulating B-Cell Compartment, Which Normalizes following Successful Treatment

(2016) Simone A. Joosten et al.   PLoS Pathogens

Innate Immune Defenses in Human Tuberculosis: An Overview of the Interactions betweenMycobacterium tuberculosisand Innate Immune Cells

(2015) Jonathan Kevin Sia et al.   Journal of Immunology Research

Chemical Biology Approaches to Designing Defined Carbohydrate Vaccines

(2014) Chakkumkal Anish et al.   CHEMISTRY & BIOLOGY

Specificity of Furanoside-Protein Recognition through Antibody Engineering and Molecular Modeling

(2014) Parnian Lak et al.   CHEMISTRY-A EUROPEAN JOURNAL

The cell envelope glycoconjugates ofMycobacterium tuberculosis

(2014) Shiva Kumar Angala et al.   CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY

Beyond macrophages: the diversity of mononuclear cells in tuberculosis

(2014) Smita Srivastava et al.   IMMUNOLOGICAL REVIEWS

IgG Subclasses and Allotypes: From Structure to Effector Functions

(2014) Gestur Vidarsson et al.   Frontiers in Immunology

Macrophages in tuberculosis: friend or foe

(2013) Evelyn Guirado et al.   Seminars in Immunopathology

Deciphering the proteome of the in vivo diagnostic reagent “purified protein derivative” from Mycobacterium tuberculosis

(2012) Yun Sang Cho et al.   PROTEOMICS

Comparative Evaluation of Profiles of Antibodies to Mycobacterial Capsular Polysaccharides in Tuberculosis Patients and Controls Stratified by HIV Status

(2011) Xian Yu et al.   Clinical and Vaccine Immunology

A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples

(2010) Margaret E. Ackerman et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Carbohydrate vaccines: developing sweet solutions to sticky situations?

(2010) Rena D. Astronomo et al.   NATURE REVIEWS DRUG DISCOVERY

Antibodies protect against intracellular bacteria by Fc receptor-mediated lysosomal targeting

(2010) N. Joller et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Structural Insights into Antibody Recognition of Mycobacterial Polysaccharides

(2009) Tomohiko Murase et al.   JOURNAL OF MOLECULAR BIOLOGY